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Abstract 
 
Obesity is a major global health problem and a risk factor for several chronic 
disorders such as diabetes, hyperlipidemia, hypertension and cardiovascular disease.  
There are various pharmacological treatments available for obesity but their use is 
limited by various adverse effects. 
Caralluma fimbriata Wall. is a plant which has been used to suppress the hunger and 
caloric intake and also help increase the endurance people.  
This review focus on patents related to caralluma fimbriata, as well as other 
nutraceutical.    
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Introduction: 
 Caralluma fimbriata is a succulent 
plant, of the cactus family, that has been 
used as a natural appetite suppressant in 
India for centuries. It is the active 
ingredient of recent patents that are 
becoming increasingly popular for their 
appetite suppressant and weight loss 
properties, as well as their ability to 
improve glycemic control (1). 
 
History of Caralluma Species: 
          Caralluma is belongs 
 Asclepiadaceae Family (Milkweed 
family) and commonly  known as 
‘Yugmaphallottama’ in Sanskrit, 
‘Maakada singi,’ in Kannada, ‘Makad 
Shing’  in Marathi, Kullee Mooliyan in 
Tamil, and  In English it is known as 
Caralluma fimbriata Wall. 
Caralluma is an erect branched 
herb, 20-30 cm tall. Stems are leafless, 4-
angled, fleshy-green, tapering to a point. 
Leaves are minute, present only on young 
branches, soon falling off, leaving a tooth-
like projection on the angles. Flowers are 
borne at the end of branches, singly or 2-3 
together on short stalks. Flowers are like 
wheels, 2 cm across. 
Petals are narrow, purple with 
yellow marking, and margins frilly with 
hairs. Fruits are 10-12 cm long, cylindric 
with one of the pairs often suppressed. 
Caralluma is found in peninsular India. It 
has been eaten in rural India for centuries, 
raw, as a vegetable with spices, or 
preserved in chutneys and pickles, and is 
often found as a roadside shrub or 
boundary marker. It has been used as a 
*Corresponding Author: 
Sharma Ravindra,  
P.G. Scholar, Dept. of P.G. Studies in 
Dravya Guna,  
National Institute of Ayurveda,  
Amer road Joravar Singh gate,  
Jaipur, Rajasthan, India, 302002  
Email: ravindramddg@gmail.com 
 
Published online in http://ijam.co.in 
ISSN:  0976-5921 
Sharma Ravindra et.al., Anti-obesity drug Caralluma fimbriata Wall. 
 
101 
portable food and thirst quencher for 
hunting. It is also used for its purported 
ability to suppress hunger and appetite and 
enhance stamina.  
Tribesmen on a day's hunt will 
often only pack some Caralluma to sustain 
themselves and hence it is commonly 
considered a "famine food" in India. Key 
phytochemical ingredients include 
pregnane glycosides, flavone glycosides, 
megastigmane glycosides, bitter principles, 
saponins and various flavonoids (2, 3). 
 
Mechanism of action:  
 Caralluma fimbriata is a 
nutraceutical derivative this is believed to 
inhibit the hunger sensory mechanism of 
the hypothalamus and increase satiety and 
satiation. It results in termination of 
adipogenesis and increased lipolysis, the 
end result being weight loss and reduced 
appetite for food (4). 
The major ingredients present in 
the extract are pregnane glycosides, 
flavone glycosides, megastigmane 
glycosides, bitter principles, saponins and 
various other flavonoids which act at the 
hypothalamus and suppress appetite, 
promote lipolysis and reduce body fat 
mass. Caralluma fimbriata blocks the 
activity of citrate lyase and results in 
blockage of the formation of fat. This 
helps reduce body weight. In the adipose 
tissue, pregnane glycosides reduce 
lipogenesis (5, 6). 
 
Pharmacological option for obesity: 
 The increasing epidemic of obesity 
has led to the need of effective 
management. Pharmacologic treatment 
and surgical treatment may be effective for 
decreasing the weight and reducing 
obesity, but in some circumstances are not 
always appropriate. Unfortunately, drug 
treatment of obesity despite short-term 
benefits, is often associated with rebound 
weight gain after the cessation of drug use, 
side effects from the medication, and the 
potential for drug abuse.  
Pharmacologic options include 
sibutramine, orlistat, phentermine, 
diethylpropion, and fluoxetine or 
bupropion. Phentermine and 
diethylpropion have potential for abuse 
and are only approved for shortterm use. 
Approved medications for long term use in 
the treatment of obesity are sibutramine 
and orlistat. However, these agents should 
be used with caution in patients with a 
history of cardiovascular disorders, and 
may cause liver disease, respectively.  
Caralluma fimbriata is a 
nutraceutical product which has no major 
adverse effects. Consequently its extract 
has beneficial advantage as compared to 
the western pharmacological and surgical 
treatment of obesity (7). 
 
Counseling of patients: 
Patients respond better to chronic drug 
therapy if they are counseled about its 
method of working.  
Kreb’s Cycle or the Citric Acid 
Cycle, takes place in the mitochondria, 
which are found in the cells of most living 
beings. Mitochondria are known as the 
body’s “powerhouse” because they 
generate energy for the body from the food 
we eat. The body obtains energy when 
carbohydrates, especially glucose 
molecules are broken down through a 
process called catabolism. This process is 
coupled with the synthesis of a high-
energy molecule called ATP (adenosine 
tri-phosphate) which provides chemical 
energy to the body, much like a car battery 
which converts chemicals to electricity.  
Glucose is broken down into a 
compound called pyruvic acid, which 
enters the mitochondria. Pyruvic acid in 
turn is broken down to Acetic acid and 
ultimately, it is converted to Acetyl co-
enzyme A and citric acid, hence the name 
Citric Acid Cycle. During this cycle, ATP 
is formed. The Kreb’s Cycle described 
above, generates energy from glucose. 
What happens when too much energy is 
generated? This is stored by the body in 
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the form of fat. When glucose rises, fat is 
formed in adipose (fat) tissue and in the 
liver through a process called 
gluconeogenesis. Fat is formed after the 
Kreb’s Cycle and is synthesized in the 
form of fatty acids. The basic building 
block of fatty acids is Acetyl co-enzyme 
A, which is mentioned above. Now, for the 
formation of Acetyl Co-enzym A, a vital 
enzyme called citrate lyase is required. If 
this enzyme is blocked, then fat cannot be 
made by the body. Caralluma fimbriata 
contains pregnane giycosides which are 
believed to block the activity of citrate 
lyase. By blocking this enzyme, Caralluma 
fimbriata blocks the formation of fat by the 
body. 
Further, Carallurna fimbriata also 
blocks another enxyme called Malonyl 
Coenzyme A. By blocking this enzyme, fat 
formation is further blocked and the body 
is forced to burn its fat reserves. This 
accelerates the rate of fat loss by the body 
(8). 
 
Adverse reaction of modern weight loss 
drug: 
 There are various drugs available 
in present market for reducing weight. 
These conventional sympathomimetic 
drugs can work as appetite suppressants 
but they carry with them the risks 
associated with sympathetic stimulation. 
These adverse effects are similar to the 
thermogenic class of drugs and include 
cardiac disturbances, elevated blood 
pressure, anxiety, insomnia and 
hypersensitivity. Fen-Phen is an infamous 
example of cardiac side effects due to their 
mechanism of action. 
Traditional health care systems, 
including nutraceutical medicine are 
widespread in developing countries. 
Various herbs, used by native people have 
been studied for their appetite suppressing 
effect, including Caralluma fimbriata 
Wall. It is also well known as a famine 
food, appetite suppressant and thirst 
quencher among tribal populations.   
Ayurvedic (traditional Indian 
medicine) experts have noted that there are 
no adverse effects when using Caralluma 
fimbriata from long time and the plant has 
no known toxic ingredient (9,10). 
 
Results of various researches 
on Caralluma fimbriata: 
The main reason why most weight-loss 
programs fail is that the patient always 
feels dull and tired after attaining weight 
loss. This makes the patient go back to his 
old eating habits and results in a rebound 
weight gain. Patients on Caralluma 
however, report feeling more energetic and 
have gained lean muscle mass, while 
losing fat.  The reason ‘for this is, that 
CaraIluma not only inhibits fat synthesis 
as mentioned above, it also increases the 
burning of fat.  This makes more energy 
available to the body and makes the patient 
more active and lively. 
According to the journal Appetite, 
researchers from Bangalore, India studied 
the effects of Caralluma fimbriata extract 
on 50 overweight men and women in a 
2006 double-blind, placebo-controlled 
study. The study participants were divided 
into two groups; one group received a 
placebo and the other received one gram 
of Caralluma fimbriata extract a day for 
60 days. At the end of the 60 days the 
placebo group experienced some weight 
loss but did not experience any statistically 
significant changes in any of the key 
measures that were taken, including body 
weight, BMI, hip and waist circumference, 
fat loss, or hunger levels (11). 
In 2004, researchers from the 
Western Geriatric Research Institute in 
Los Angeles implemented a double-blind, 
placebo-controlled study, this time with 26 
people. The study showed that more than 
60 percent of the participants who 
took Caralluma fimbriata extract every 
day for one month lost six pounds or more, 
while the placebo group showed little to no 
weight loss. 72 percent of the participants 
taking the extract also had a reduction in 
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waist circumference. The study concluded 
that Caralluma fimbriata does indeed 
promote weight loss and fat reduction.  
Participants taking the extract also 
reported greater energy levels (12). 
Thus, by acting on different levels 
in the body’s biochemical processes and 
brain function, Caralluma fimbriata works 
as an effective appetite suppressant and 
potent weight-loss agent; which are 
supported by various researches done by 
researcher through out of the world. 
 
Conclusion: 
 Obesity is recognized as one of the 
major global health issues that requires 
intervention. Weight reduction by non 
pharmacological methods such as diet and 
exercise is advised, but these methods 
have limited effect in obese people. Drugs 
for obesity currently available in market 
have side effects which prevent their use in 
a large proportion of patient.  
 Caralluma fimbriata is a potential 
appetite suppressor that can be used as an 
effective and safe therapy for the 
management of obesity. 
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